Pascale Flandrin-Gresta

10PUBLICATIONS
64CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry.

|Aug 21, 2025
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.

Jules Higué, Corentin Orvain, Pierre-Yves Dumas

|Apr 24, 2025
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Nicolas Gazeau, David Beauvais, Rémi Tilmont

|Apr 01, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Lucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans

|Oct 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia.

Romane Joudinaud, Augustin Boudry, Laurène Fenwarth

|Jul 18, 2024
Quantification of Urinary Exosomal Prostate-Specific Antigen for the Diagnosis of Prostate Cancer Using Clinical Laboratory-Based Techniques: Protocol for a Case-Control Study.

Guorong Li, Yannick Tholance, Nora Mallouk

Pageof 2

Frequent Collaborators

3 joint publications

Audrey Bidet

2 joint publications

Pierre Sujobert

2 joint publications

Guorong Li

2 joint publications

Nora Mallouk